Literature DB >> 11030825

Macular degeneration associated with aberrant expansion of trinucleotide repeat of the SCA7 gene in 2 Japanese families.

T Abe1, T Tsuda, M Yoshida, Y Wada, T Kano, Y Itoyama, M Tamai.   

Abstract

OBJECTIVE: To evaluate the macular function of Japanese patients with a trinucleotide repeat expansion in the spinocerebellar ataxia type 7 (SCA7) gene.
METHODS: Ophthalmic findings in patients whose DNA analysis revealed expanded alleles of the trinucleotide repeat in the SCA7 gene were evaluated.
RESULTS: Trinucleotide repeat was expanded from 40 to 48 in affected patients (control subjects, 12 repeats). Affected patients were characterized by different degrees of visual acuity decrease (0.09-0.9), a tritan axis color vision, a coarse granular appearance of the macular region on scanning laser ophthalmoscopy, depression of multifocal electroretinograms, and macular degeneration. However, pigmentary changes were not observed in the retina. The trinucleotide repeat was longer and the onset of macular dysfunction was earlier in the younger generation. One patient in a family manifested decreased visual acuity 10 years preceding other neurologic signs. CONCLUSIONS AND CLINICAL RELEVANCE: Patients with SCA7 mutations showed macular dysfunction or degeneration with expansion of CAG repeat in the SCA7 gene. However, the lesions were less pigmented than those previously reported. Patients also showed ophthalmologic anticipation, which has not been reported for the ocular changes in other patients who have trinucleotide repeat expansion of the responsible genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030825     DOI: 10.1001/archopht.118.10.1415

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  Somatic instability of expanded CAG repeats of ATXN7 in Japanese patients with spinocerebellar ataxia type 7.

Authors:  Satoshi Katagiri; Takaaki Hayashi; Tomokazu Takeuchi; Hisashi Yamada; Tamaki Gekka; Kiyokazu Kawabe; Akira Kurita; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2015-02-03       Impact factor: 2.379

2.  Progress of macular atrophy during 30 months' follow-up in a patient with spinocerebellar ataxia type1 (SCA1).

Authors:  Ayane Hirose; Satoshi Katagiri; Takaaki Hayashi; Tomokazu Matsuura; Norihiro Nagai; Kaoru Fujinami; Takeshi Iwata; Kazushige Tsunoda
Journal:  Doc Ophthalmol       Date:  2020-07-09       Impact factor: 2.379

3.  Retinal Nerve Fibre Layer and Macular Thinning in Spinocerebellar Ataxia and Cerebellar Multisystem Atrophy.

Authors:  John H Pula; Vernon L Towle; Victoria M Staszak; Dingcai Cao; Jacqueline T Bernard; Christopher M Gomez
Journal:  Neuroophthalmology       Date:  2011-06

Review 4.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 5.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

6.  Clinical characterization and the improved molecular diagnosis of autosomal dominant cone-rod dystrophy in patients with SCA7.

Authors:  Xuan Zou; Fengxia Yao; Fengrong Li; Shijing Wu; Hui Li; Zixi Sun; Tian Zhu; Xing Wei; Donghui Li; Ruifang Sui
Journal:  Mol Vis       Date:  2021-05-07       Impact factor: 2.367

7.  Clinical Characteristics of Neuronal Intranuclear Inclusion Disease-Related Retinopathy With CGG Repeat Expansions in the NOTCH2NLC Gene.

Authors:  Natsuko Nakamura; Kazushige Tsunoda; Akihiko Mitsutake; Shota Shibata; Tatsuo Mano; Yu Nagashima; Hiroyuki Ishiura; Atsushi Iwata; Tatsushi Toda; Shoji Tsuji; Hiromasa Sawamura
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.